Drug Type CAR-T |
Synonyms- |
Target |
Action inhibitors |
Mechanism BCMA inhibitors(B-cell maturation protein inhibitors), CD19 inhibitors(B-lymphocyte antigen CD19 inhibitors), Gene transference |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
B-cell lymphoma refractory | Phase 1 | - | 05 May 2021 | |
Diffuse large B-cell lymphoma recurrent | Phase 1 | - | 05 May 2021 | |
High grade B-cell lymphoma | Phase 1 | - | 05 May 2021 | |
Mediastinal large B-cell lymphoma | Phase 1 | - | 05 May 2021 |